How are KURA long call max profit and max loss calculated?

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the KURA long call priced from the end-of-day chain at a 30-day expiry (ATM IV 83.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$90.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a KURA long call?

The breakeven for the KURA long call priced on this page is roughly $9.90 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current KURA market-implied 1-standard-deviation expected move is approximately 23.91%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current KURA implied volatility affect this long call?

KURA ATM IV is at 83.40% with IV rank near 9.82%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

KURA Long Call Strategy

KURA (Kura Oncology, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.

KURA (Kura Oncology, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $841.5M, a beta of 0.32 versus the broader market, a 52-week range of 5.45-12.49, average daily share volume of 1.4M, a public-listing history dating back to 2015, approximately 192 full-time employees. These structural characteristics shape how KURA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.32 indicates KURA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a long call on KURA?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current KURA snapshot

As of May 13, 2026, spot at $9.46, ATM IV 83.40%, IV rank 9.82%, expected move 23.91%. The long call on KURA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.

Why this long call structure on KURA specifically: KURA IV at 83.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a KURA long call, with a market-implied 1-standard-deviation move of approximately 23.91% (roughly $2.26 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated KURA expiries trade a higher absolute premium for lower per-day decay. Position sizing on KURA should anchor to the underlying notional of $9.46 per share and to the trader's directional view on KURA stock.

KURA long call setup

The KURA long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With KURA near $9.46, the first option leg uses a $9.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed KURA chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 KURA shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$9.00	$0.90

KURA long call risk and reward

Net Premium / Debit: -$90.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$90.00
Breakeven(s): $9.90
Risk / Reward Ratio: Unbounded

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

KURA long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on KURA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.9%	-$90.00
$2.10	-77.8%	-$90.00
$4.19	-55.7%	-$90.00
$6.28	-33.6%	-$90.00
$8.37	-11.5%	-$90.00
$10.46	+10.6%	+$56.28
$12.55	+32.7%	+$265.33
$14.64	+54.8%	+$474.39
$16.73	+76.9%	+$683.44
$18.82	+99.0%	+$892.50

When traders use long call on KURA

Long calls on KURA express a bullish thesis with defined risk; traders use them ahead of KURA catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

KURA thesis for this long call

The market-implied 1-standard-deviation range for KURA extends from approximately $7.20 on the downside to $11.72 on the upside. A KURA long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current KURA IV rank near 9.82% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on KURA at 83.40%. As a Healthcare name, KURA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to KURA-specific events.

KURA long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. KURA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move KURA alongside the broader basket even when KURA-specific fundamentals are unchanged. Long-premium structures like a long call on KURA are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current KURA chain quotes before placing a trade.

Frequently asked questions

What is a long call on KURA?: A long call on KURA is the long call strategy applied to KURA (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With KURA stock trading near $9.46, the strikes shown on this page are snapped to the nearest listed KURA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are KURA long call max profit and max loss calculated?: Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the KURA long call priced from the end-of-day chain at a 30-day expiry (ATM IV 83.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$90.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a KURA long call?: The breakeven for the KURA long call priced on this page is roughly $9.90 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current KURA market-implied 1-standard-deviation expected move is approximately 23.91%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on KURA?: Long calls on KURA express a bullish thesis with defined risk; traders use them ahead of KURA catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current KURA implied volatility affect this long call?: KURA ATM IV is at 83.40% with IV rank near 9.82%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.